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Abstract
Objectives: To assess whether people with learning disability in the UK have poorer access to cancer screening.
Design: Four cohort studies comparing people with and without learning disability, within the recommended age ranges
for cancer screening in the UK. We used Poisson regression to determine relative incidence rates of cancer screening.
Setting: The Health Improvement Network, a UK primary care database with over 450 General practices.
Participants: Individuals with a recorded diagnosis of learning disability including general diagnostic terms, specific
syndromes, chromosomal abnormalities and autism in their General Practitioner computerised notes. For each type of
cancer screening, a comparison cohort of up to six people without learning disability was selected for each person with a
learning disability, using stratified sampling on age within GP practice.
Main outcome measures: Incidence rate ratios for receiving 1) a cervical smear test, 2) a mammogram, 3) a faecal occult
blood test and 4) a prostate specific antigen test.
Results: Relative rates of screening for all four cancers were significantly lower for people with learning disability. The
adjusted incidence rate ratios (95% confidence intervals) were Cervical smears: Number eligible with learning
disability = 6,254; IRR = 0.54 (0.52–0.56). Mammograms: Number eligible with learning disability = 2,956; IRR = 0.76 (0.72–
0.81); Prostate Specific Antigen: Number eligible = 3,520; IRR = 0.87 (0.80–0.96) and Faecal Occult Blood Number
eligible = 6,566; 0.86 (0.78–0.94). Differences in screening rates were less pronounced in more socially deprived areas.
Disparities in cervical screening rates narrowed over time, but were 45% lower in 2008/9, those for breast cancer screening
appeared to widen and were 35% lower in 2009.
Conclusion: Despite recent incentives, people with learning disability in the UK are significantly less likely to receive
screening tests for cancer that those without learning disability. Other methods for reducing inequalities in access to cancer
screening should be considered.
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Introduction
People with learning disabilities have high rates of physical
morbidity and co-occurring physical disorders [1,2]. In 2006, the
UK Disability Rights Commission (DRC; now Equality and
Human Rights Commission) highlighted inequalities, describing
‘‘diagnostic overshadowing’’ whereby professionals may be
distracted from physical health conditions because of the primary
diagnosis of a learning disability [3,4]. The report called for better
access to physical health care in this group of patients.
Furthermore, health and social care professionals have failed to
meet the medical needs of individuals with learning disabilities
when admitted to hospital [5]. These health inequalities may be
widening and health and social services have a role to ensure that
routine physical services including cancer screening are provided
equitably, are targeted to those with the greatest needs and are
acceptable to those who need them most. The DRC recom-
mended that a register of those with learning disability should be
instigated in UK in primary care [4]. This register had also been
recommended in the Department of Health white paper ‘‘valuing
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people’’ in 2001 [6], with an expectation of compliance by 2004. A
learning disability register has been part of the English primary
care Quality Outcomes Framework (QOF), a financial incentive
scheme for General Practitioners to improve quality of care, for
adults over 18, since 2006/7. It is recommended that people on
the register should receive an annual physical health check, but the
content of the check is not specified. In 2008, the Department of
Health for England made funding available for general practices to
provide health checks for people with learning disabilities, but
uptake by individual practices was optional, as part of a Directed
Enhanced Service [7].
The UK NHS Cancer Screening Programmes offer age-
targeted screening to the UK general population, based on the
best available evidence regarding the effectiveness and risks of
screening tests at different ages. They published guidance in 2006
to improve access to both breast and cervical screening
programmes for people with learning disability [8]. This empha-
sised that people with learning disability should routinely be
offered breast and cervical screening. In particular they stressed
that no assumption should be made that these groups are not at
risk of cervical cancer, on account of presumed sexual inactivity.
Specific health promotion materials are available for people with
learning disability, including picture books which explain both
cervical and breast screening [8].
We aimed to explore whether rates of cancer screening differed
in people with learning disability compared to people without such
a diagnosis, in primary care. Our primary focus was the
established screening programmes, namely cervical and breast
cancer. Our secondary outcomes were screening rates for prostate
and bowel cancer. We also aimed to explore whether any
differences in cancer screening rates had changed over the last
decade, and whether they varied by geographical social depriva-
tion. We hypothesised that for the established screening pro-
grammes (cervical and mammography) rates of screening would be
lower in people with learning disability. We also hypothesised that
other screening rates for bowel and prostate cancer would be lower
and that differences in the established screening programmes
would have narrowed in more recent years and that disparities
would be more marked in areas of greater social deprivation.
Methods
Ethics Statement
The Health Improvement Network (THIN) scheme of provid-
ing anonymised data to researchers was approved by the NHS
South-East Multi-centre Research Ethics Committee in 2002.
Further, this study received scientific approval from THIN
scientific review committee, reference 10-016.
Study Design
Retrospective cohort studies.
Setting
United Kingdom primary care.
Data Source
The Health Improvement Network (THIN), a primary care
research database which extracts anonymised data entered during
routine clinical practice, from general practices across the United
Kingdom [9]. At the time this study was conducted the database
included over 9 million patients, with more than 50 million years
of patient data from over 450 general practices. In 2009, the active
patients in THIN represented approximately 6% of the UK
population. The distribution of THIN practices across UK
countries reflects the distribution of the UK population. Therefore
75% of the practices were located in England, 5% in Northern
Ireland, 13% in Scotland and 6% in Wales. In UK, health care is
free and 98% of the population is registered with a general
practice. Learning Disability is one of the conditions for which a
disease register is incentivised by QOF, and therefore identifica-
tion of known cases of learning disability in GP data is likely to be
relatively complete since the introduction of this register in 2006.
THIN includes information for each individual on diagnoses,
prescriptions, referrals, some risk factors for poor health including
smoking, and local area deprivation (Townsend score [10]). GPs
and practice staff use a Read code system to enter diagnoses,
symptoms, investigations (including screening tests) and lifestyle
information into the electronic clinical notes. Read codes are a
well established hierarchical coding system, which provide
standardised options for entering different diagnoses and other
clinical information, and the codes are aligned to international
medical coding systems such as the WHO ICD coding system.
The Read code system became accepted as a standard in UK
primary care in 1988 [11].
Participants
For each type of cancer screening, such as cervical or breast
screening, the age eligibility criteria for screening differ. Therefore
we created four separate cohorts of people with learning disability
who met these eligibility criteria (one for each of type of cancer),
and also extracted data regarding four stratified random compar-
ison cohorts of people without learning disability diagnoses who
were also eligible for the screening. The age eligibility criteria and
recommendations regarding frequency of screening also vary by
country within the UK and therefore we matched our inclusion
criteria to these recommendations. These inclusion criteria are
specified below for each type of cancer screening.
For all participants we only included people after their general
practice had met predefined data quality criteria within THIN
[12] and who had a minimum of six months follow-up data,
between 1999 and December 2009.
People with learning disability (the exposed
cohorts). We identified all people with a diagnostic record for
a learning disability. We developed Read code lists for these
diagnoses using methodology previously described [13]. We
included general terms for learning disability (including QOF
codes), as well as terms relating to 1) autism including Asperger
syndrome and 2) chromosomal abnormalities such as Down
syndrome and Fragile X syndrome. A full list of the terms included
are available from the authors.
People without learning disability (the unexposed
cohorts). For each learning disability cohort, we extracted data
regarding up to six comparison participants of the same sex who
did not have a diagnosis of a learning disability in their practice
record. Selecting a greater number of unexposed participants
maximises the statistical power of a study, which is particularly
helpful in a situation where the number of exposed individuals (ie
with learning disability) is fixed. We use random stratified
sampling within five-year age bands from the same practice to
ensure these comparison cohorts were similar in terms of age and
practice-level variables.
Age Inclusion Criteria and Follow-up Period for Different
Cancer Screening Programmes
There are different NHS cancer screening programmes for
cervical, breast and bowel cancer in the UK, which have varied
over time and in the different UK countries. There is not a cancer
screening programme for prostate cancer, but men are given
Cancer Screening in Learning Disability
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information in a ‘‘Prostate Specific Antigen Informed Choice
Programme’’. The age criteria we employed reflect these
differences, as detailed below.
1) Cervical cancer screening cohorts. In England, before
2003, the recommended frequency of screening in England ranged
between 3 and 5 years for women aged 20 to 65 years. A new
cervical cancer screening program began in 2003 for all women
aged between 25 and 65. The screening frequency differed by age,
being every 3 years for women between 25 to 49 years of age and
every five years for those aged 50 to 64. In Scotland cervical
screening is routinely offered every three years to women aged
between 20 and 60 years of age. In Wales screening is routinely
offered every three years to women aged between aged 20 to 64.
In Northern Ireland, all women between the ages of 20 and 64 are
invited every five years.
We started follow-up for women from the latest date of GP
registration, their 20th birthday (or 25th for English practices after
2003) or January 1st 1998. Their exit date from the cervical
screening cohort was defined as earliest date of leaving the general
practice, their 65th birthday (60th in Scotland). We also stopped
follow-up when a reason for a change in cervical screening
frequency was recorded in their clinical record including
hysterectomy, testing positive for Human Papilloma Virus
(HPV), the identification of precancerous cells, a diagnosis of
cervical cancer or death.
For cervical screens, the general practice records allow an
indicator for whether a patient should be excluded from screening,
together with the date of the exclusion. A reason for excluding
patients can also be recorded, although in practice this is
completed for less than a third of patients. The reasons for
exclusion can include reaching upper age limit for screening,
hysterectomy, being considered ‘‘inappropriate for screening’’, or
patient refusal. Our main analysis omitted these excluded patients.
However we did explore the extent to which GP exclusions had an
effect on differences in cervical screening rates. We did this by also
calculating a relative rate of screening which included all patients
in the cohort, irrespective of whether the GP had excluded them
from cervical screening.
Exclusion indicators are not available within the Read Code
system for the other screening tests.
2) Breast cancer screening cohorts. Since 1993, women in
England, Ireland, Scotland and Wales aged between 50 and
64 years have been automatically invited for mammograms every
three years.
In the breast screening cohort we began follow up at the latest
date of registering at the general practice, reaching their 50th
birthday or January 1st 1998. Women left the cohort at the earliest
date of the following: leaving the general practice, 64th birthday, or
a medical diagnosis of mastectomy, precancerous cells, breast
cancer or death.
3) Bowel cancer screening cohorts. The NHS Bowel
Cancer Screening Programme in England was initiated in July
2006. It offers screening every two years to all men and women
aged 60 to 69. People over 70 can request a screening kit. Similar
programmes are being implemented in Scotland and Wales but
are at different stages and Northern Ireland only began rolling out
the programme in December 2009. Colonoscopy is offered to
those who receive an abnormal FOB result. In the future, it is
planned that one-off flexible sigmoidoscopy will be offered to
everybody aged 55.
For bowel cancer screening we began follow-up for people at
the latest date of registration at a general practice, their 60th
birthday or January 1st 1998. Follow-up ceased at the earliest date
of leaving the general practice, their 70th birthday, of a medical
record of colorectal cancer diagnosis or death.
4) Prostate Screening Cohorts. The prostatic specific
antigen (PSA) test is not currently recommended as a routine
screening test for prostate cancer in the UK. However, the PSA
informed choice programme involves GPs providing information
to men who inquire about PSA testing and undertaking PSA tests
with informed decision-making.
For the prostate screening cohort we began follow up for men at
the latest date of their 50th birthday, registering at a general
practice, or January 1st 1998. We ended follow-up at the earliest of
leaving the general practice, their 70th birthday, or when there was
a GP record of prostate cancer diagnosis or death.
Outcomes
The main outcomes for the study were a clinical record of 1)
attending for cervical screening 2) attending for mammography (or
a mammography result). 3) a Faecal Occult Blood Test result or 4)
a PSA result.
Covariates
We considered age, gender, and Townsend index as potential
confounders. The Townsend index is a validated marker of the
social deprivation of a geographical area [10]. In THIN, each
patient is assigned a score according to their residential postcode in
the UK. The data are available at a level of approximately 150
households and the patient is assigned a quintile of deprivation
according to the deprivation of their area with national normative
data as the reference group. The higher the deprivation quintile,
the greater the social deprivation. Townsend scores are comprised
of four indices of deprivation for an area; namely the percentage
unemployed; the percentage of households who are homeowners
and own a car, and level of overcrowding [10].
Analysis
First we explored temporal trends in the recording of learning
disability and the frequency with which different learning disability
codes were used over time. We calculated incidence rates and rate
ratios (IRRs) for receiving a screening test for each cancer using
Poisson Regression, comparing the cohorts with and without
learning disabilities. We produced unadjusted IRRs and then we
adjusted the models for age, sex (only for bowel cancer since the
other screens only apply to one sex) and country, and then for age,
(sex), country and deprivation score. All models included the
general practice as a random effect to account for clustering within
practice. For the established screening programmes (cervical and
breast), likelihood ratio tests were used to compare models with
and without interactions between learning disability and 1)
calendar period 2) age 3) deprivation quintile and 4) country.
Where significant interactions were identified, stratified regression
analyses were performed. Any time trends were explored using
segmented regression analysis.
All analyses were performed using Stata version 12.
Results
Time trends in the recording of learning disability within the
THIN database are depicted in figure 1, spanning the study period
between 1999 and 2009. Predictably there was a peak in recording
Quality Outcomes Framework (QoF) codes for learning disability
after the implementation of the learning disability QOF in 2006.
There was a steady increase in the recording of autism across the
decade which was more pronounced for males. Time trends in the
use of codes for chromosomal syndromes related to learning
Cancer Screening in Learning Disability
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disability showed no clear pattern and the observed changes may
reflect general variance due to the smaller numbers of people
involved.
Table 1 describes the cohorts with and without learning
disability who were included in each of the cervical, breast, bowel
and prostate screening comparisons. This includes their distribu-
tion by age, sex, deprivation score, year of entry to the cohort and
country of residence in the UK. The total numbers of eligible
people in the learning disability cohorts exceeded 6000 for the
cervical and bowel screening comparisons with fewer people in the
breast (n = 2956) and prostate (n = 3520) screening cohorts
(Table 1).
The unadjusted incidence rates for cancer screening are
presented in table 2 and figure 2. These screening rates are more
informative than the absolute numbers screened since they account
for the length of follow-up time available in THIN for each
individual. The screening rates are presented by time period,
Townsend quintile for deprivation and by country. Absolute rates
of screening for all four cancers were lower in people with learning
disability. Rates of recording of screening in THIN were
comparable to rates published elsewhere. For those with at least
3 years follow-up, breast screening rates were 81% in the
comparison cohort (compared with 75% in reported rates for
the general population [14). Cervical screening rates in the
comparison cohort were 97%.
The results of the poisson regression analysis (using the whole
sample) are presented in table 3, with incidence rate ratios for
cancer screening. The analysis confirmed that people with
learning disability were significantly less likely to receive screening
for all four cancers we studied. Accounting for age, period and
country had minimal impact on the results.
Exemption from cervical cancer screening was more common
in people with learning disability, 25% compared to 6% in the
comparison cohort. Where recorded, the most common reasons
were refusal or being deemed inappropriate for screening. Our
main analysis omitted these excluded patients. Before accounting
for this exclusion reporting, the people with learning disabilities
were 56% less likely to be screened than their counterparts of
Figure 1. Time trends in use of diagnostic codes for learning disability in the THIN database 1999–2009. The figure charts time trends
in the rates of recording of different diagnostic codes for learning disability (LD) by general practitioners in the UK THIN databse between 1999–2009.
Separate graphs are provided for general learning disability diagnoses, autism and related diagnoses, chromosomal conditions associated with
learning disability, and read codes used for the Quality Outcomes Framework (QoF). QoF is a financial incentive scheme to improve quality of primary
care in England, and a register of those with learning disabilty became part of this scheme in 2006/7.
doi:10.1371/journal.pone.0043841.g001
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normal intelligence (unadjusted IRR for cervical screening: 0.44,
95%CI; 0.42–0.46). However, recorded exclusions did not fully
account for the difference in cervical screening rates. In our main
analysis, people with learning disability were 45% less likely to be
screened (Table 3: unadjusted IRR for cervical screening= : 0.55,
95%CI; 0.53–0.57).
The analysis of interactions for the established screening
programmes identified significant differences according to time
period, Townsend score and for country (cervical screening only).
There was less disparity in cancer screening among people living
in the most deprived areas of the UK (tables 2 and 3); in fact
discrepancies in screening rates were more pronounced in the least
deprived areas of each country. Cervical and breast screening were
relatively less common in people with learning disability in all four
countries of the UK (Tables 2 and 3). These interactions were
most consistent for cervical cancer screening and stratified analyses
are presented in table 4. Differences in rates of cervical cancer
screening became less pronounced over the decade, and the time
trend analysis derived three distinct time trend periods (shown in
table 4). In 2008/9 people with learning disability were still 45%
less likely to be screened that their counterparts without learning
disability (Table 4: adjusted IRR for cervical screening in 2008/
9:0.55 (0.53–0.57)). Although the differences in mammography
screening showed less consistent trends statistically, they appeared
to widen over the decade, (IRR in 1999:0.84; 0.62–1.13. IRR in
2009:0.65; 0.54–0.78). Disparities in screening rates for both
cancers were least pronounced in the more socially deprived areas
(cervical cancer; table 4). For breast screening the IRR in the least
deprived areas was 0.69 (0.59–0.80), in contrast to 0.93 (0.80–1.08)
in the most deprived areas. The differences in cervical screening
rates for people with and without learning disabilities were similar
in England, Ireland and Scotland but the difference appeared to
be slightly greater in Wales (Table 4).
Discussion
People with a diagnosis of learning disability in primary care have
fewer recorded screening tests for both cervical and breast cancer,
compared to demographically similar general practice comparison
patients. They are also less likely to have a record of testing for faecal
Table 1. Description of cohorts with and without learning disability eligible to be screened for the four types of cancer.
Cervical cohort Mammogram cohort PSA cohort FOB cohort
No LD LD No LD LD No LD LD No LD LD
Total Number 33,425 6,254 17,354 2,956 20,091 3,520 40,225 6,566
Mean age cohort entry (SD) 35.8 (10.3) 36.6 (11.1) 57.7(10.0) 57.5(10.0) 54.3 (5.1) 54.9 (5.7) 55.0 (5.8) 55.0 (5.7)
Median years follow-up time (IQR) 5.8 (2.6–9.7) 6.7 (3.2–10.4) 5.4 (2.4–9.4) 6.4 (2.9–10.3) 5.5 (2.5–9.4) 6.4 (3.0–9.9) 5.5 (2.4–9.4) 6.4 (3.0–10.1)
Males (%) NA NA NA NA 20,091 3,520 21810 (54) 3593 (55)
Females (%) 33,425 6,254 17,354 2,956 NA NA 18415 (46) 2973 (45)
Time period (%)
1999 6738 (20) 1472 (24) 3866 (22) 503 (17) 4758 (24) 653 (19) 9747 (24) 1223 (19)
2000 4090 (12) 708 (11) 1677 (10) 262 (9) 1926 (10) 321 (9) 3645 (9) 567 (9)
2001 3871 (12) 638 (10) 1637 (9) 232 (8) 1677 (8) 250 (7) 3485 (9) 465 (7)
2002 3519 (11) 624 (10) 1490 (9) 245 (8) 1667 (8) 262 (7) 3222 (8) 500 (8)
2003 3031 (9) 529 (8) 1639 (9) 275 (9) 1833 (9) 352 (10) 3641 (9) 627 (10)
2004 2641 (8) 483 (8) 1387 (8) 262 (9) 1630 (8) 315 (9) 3191 (8) 575 (9)
2005 2244 (7) 427 (7) 1336 (8) 251 (8) 1433 (7) 279 (8) 2893 (7) 524 (8)
2006 1915 (6) 298 (5) 1092 (6) 212 (7) 1277 (6) 250 (7) 2535 (6) 469 (7)
2007 2134 (6) 353 (6) 1162 (7) 239 (8) 1360 (7) 286 (8) 2738 (7) 540 (8)
2008 1831 (5) 362 (6) 1088 (6) 262 (9) 1307 (7) 297 (8) 2581 (6) 582 (9)
2009 1411 (4) 360 (6) 980 (6) 213 (7) 1223 (6) 255 (7) 2547 (6) 494 (8)
Social deprivation score (%)
Missing 1464 (4) 253 (4) 624 (4) 127 (4) 720 (4) 165 (5) 1312 (3) 307 (5)
1 (least deprived) 7092 (21) 1027 (16) 4146 (24) 482 (16) 4757 (24) 455 (13) 9617 (24) 915 (14)
2 6554 (20) 991 (16) 3627 (21) 441 (15) 4384 (22) 639 (18) 8888 (22) 1081 (16)
3 6924 (21) 1246 (20) 3442 (20) 619 (21) 4002 (20) 687 (20) 8056 (20) 1334 (20)
4 6537 (20) 1437 (23) 3232 (19) 691 (23) 3582 (18) 843 (24) 7202 (18) 1561 (24)
5 (most deprived) 4854 (15) 1300 (21) 2283 (13) 596 (20) 2646 (13) 731 (21) 5150 (13) 1368 (21)
Country (%)
England 25550 (76) 4789 (77) 13409 (77) 2285 (77) 15613 (78) 2717 (77) 31496 (78) 5102 (78)
Ireland 1661 (5) 292 (5) 732 (4) 129 (4) 809 (4) 147 (4) 1690 (4) 280 (4)
Scotland 4239 (13) 774 (12) 2182 (13) 370 (13) 2574 (13) 461 (13) 4795 (12) 812 (12)
Wales 1975 (6) 399 (6) 1031 (6) 172 (6) 1095 (5) 195 (6) 2244 (6) 372 (6)
LD Learning Disability PSA Prostate Specific Antigen Test FOB Faecal Occult Blood Test.
doi:10.1371/journal.pone.0043841.t001
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occult bloods or prostatic specific antigen. Over the decade we
studied, differences in rates of cervical cancer screening narrowed,
but by 2008/9 people with learning disability were still 45% less
likely to receive a screen. Rates of mammography recording showed
less consistent patterns, in 2009 people with learning disability were
35% less likely to receive a mammogram than the comparison
group. Differences in rates of screening for breast and cervical
cancer are significantly more prominent for people living in less
socially deprived geographical areas. For cervical cancer, people
with learning disability are less likely to be screened than the general
population if they live in more affluent areas. For breast cancer, the
rates of screening for people with learning disability show less
variation by social deprivation. Our findings differed slightly in the
four countries of the UK. In particular relative rates of cervical
cancer screening were significantly lower for people with learning
disability in Wales.
Table 2. Incidence rates per 100 person years for cancer screening by time period, Townsend quintile for deprivation and by
country.
Cervical cohort Mammogram cohort PSA cohort FOB cohort
No LD LD No LD LD No LD LD No LD LD
Time period
1999 40.65 (38.80–
42.57)
17.44 (15.12–
20.03)
24.53 (22.20–
27.03)
25.02 (18.74–
32.73)
2.13 (1.71–
2.63)
1.28 (0.51–
2.63)
0.38 (0.26–
0.54)
0.87 (0.40–
1.65)
2000 38.17 (36.68–
39.70)
15.11 (13.27–
17.13)
25.16 (23.20–
27.24)
23.30 (18.45–
29.04)
2.67 (2.27–
3.14)
2.21 (1.31–
3.49)
0.49 (0.37–
0.64)
0.60 (0.27–
1.14)
2001 42.72 (41.21–
44.28)
17.02 (15.19–
19.01)
22.64 (20.93–
24.46)
19.53 (15.49–
24.31)
3.17 (2.76–
3.62)
2.54 (1.64–
3.75)
0.28 (0.20–
0.38)
0.54 (0.26–
1.00)
2002 42.35 (40.89–
43.85)
18.79 (16.97–
20.76)
28.75 (26.90–
30.68)
30.55 (25.72–
36.03)
3.73 (3.32–
4.18)
2.69 (1.83–
3.82)
0.29 (0.21–
0.39)
0.32 (0.13–
0.65)
2003 44.70 (43.09–
46.34)
19.51 (17.58–
21.60)
28.91 (27.12–
30.78)
23.05 (19.15–
27.53)
4.01 (3.60–
4.44)
1.60 (1.00–
2.43)
0.44 (0.35–
0.54)
0.27 (0.11–
0.55)
2004 50.14 (48.37–
51.96)
29.92 (27.46–
32.54)
29.48 (27.67–
31.37)
21.38 (17.75–
25.52)
4.48 (4.06–
4.92)
2.95 (2.16–
3.93)
0.31 (0.24–
0.40)
0.54 (0.31–
0.87)
2005 56.07 (54.06–
58.13)
39.64 (36.52–
42.96)
30.22 (28.38–
32.15)
22.59 (18.98–
26.69)
4.35 (3.96–
4.78)
3.45 (2.62–
4.45)
0.58 (0.48–
0.69)
0.58 (0.35–
0.90)
2006 54.03 (51.87–
56.25)
34.66 (31.44–
38.12)
28.13 (26.30–
30.05)
25.25 (21.37–
29.63)
4.44 (4.04–
4.86)
3.96 (3.08–
5.01)
0.55 (0.46–
0.65)
0.84 (0.56–
1.20)
2007 58.36 (55.99–
60.80)
38.12 (34.46–
42.06)
31.67 (29.66–
33.77)
22.34 (18.69–
26.49)
4.49 (4.09–
.91)
4.58 (3.64–
5.70)
2.21 (2.03–
2.41)
1.61 (1.22–
2.08)
2008 67.64 (64.92–
70.45)
39.18 (35.23–
43.46)
30.17 (28.19–
32.26)
23.56 (19.88–
27.72)
4.57 (4.17–
4.99)
4.62 (3.68–
5.72)
5.70 (5.40–
6.01)
4.40 (3.75–
5.12)
2009 88.06 (84.39–
91.84)
48.78 (44.09–
53.82)
29.88 (27.85–
32.01)
24.49 (20.69–
28.79)
4.92 (4.50–
5.36)
4.92 (3.95–
6.05)
7.16 (6.82–
7.52)
5.14 (4.43–
5.92)
Social deprivation
score
1 (least deprived) 50.30 (49.06–
51.55)
23.45 (21.68–
25.32)
30.91 (29.67–
32.19)
25.23 (21.88–
28.95)
5.06 (4.77–
5.36)
3.67 (2.85–
4.65)
2.19 (2.06–
2.32)
1.76 (1.37–
2.23)
2 49.94 (48.66–
51.25)
23.01 (21.24–
24.88)
28.45 (27.21–
29.74)
21.68 (18.53–
25.21)
4.44 (4.17–
4.74)
3.76 (3.06–
4.56)
2.03 (1.90–
2.16)
1.91 (1.54–
2.35)
3 50.58 (49.30–
51.89)
25.48 (23.77–
27.29)
30.10 (28.73–
31.53)
25.50 (22.64–
28.62)
3.88 (3.61–
4.17)
3.95 (3.26–
4.75)
1.93 (1.80–
2.07)
1.47 (1.18–
1.80)
4 48.68 (47.39–
49.99)
28.97 (27.22–
30.80)
26.97 (25.66–
28.32)
22.94 (20.49–
25.61)
3.50 (3.22–
3.80)
3.31 (2.75–
3.94)
1.90 (1.76–
2.05)
1.61 (1.33–
1.92)
5 (most deprived) 46.17 (44.73–
47.65)
30.59 (28.66–
32.60)
23.23 (21.83–
24.71)
23.38 (20.67–
26.34)
3.02 (2.72–
3.34)
2.98 (2.43–
3.63)
1.76 (1.60–
1.94)
2.00 (1.67–
2.38)
Country
England 49.84 (49.18–
50.50)
27.35 (26.43–
28.30)
31.91 (31.18–
32.65)
27.17 (25.57–
28.84)
4.20 (4.06–
4.35)
3.44 (3.11–
3.79)
2.32 (2.25–
2.40)
1.91 (1.73–
2.09)
Ireland 40.27 (38.15–
42.47)
24.02 (20.70–
27.72)
26.70 (24.30–
29.27)
19.12 (14.75–
24.37)
6.20 (5.42–
7.05)
4.77 (3.22–
6.81)
1.39 (1.15–
1.65)
1.89 (1.23–
2.77)
Scotland 53.35 (51.62–
55.13)
27.68 (25.32–
30.20)
16.94 (15.84–
18.10)
12.96 (10.70–
15.55)
2.51 (2.24–
2.81)
2.66 (2.01–
3.45)
0.46 (0.38–
0.56)
0.95 (0.66–
1.32)
Wales 47.70 (45.38–
50.10)
18.89 (16.41–
21.63)
19.72 (17.85–
21.74)
14.68 (10.82–
19.46)
5.14 (4.53–
5.81)
5.17 (3.69–
7.04)
0.97 (0.79–
1.17)
0.81 (0.43–
1.38)
LD Learning Disability, PSA Prostate Specific Antigen Test, FOB Faecal Occult Blood Test. (95% confidence intervals).
doi:10.1371/journal.pone.0043841.t002
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Strengths and Limitations
Our study included a large representative sample of people with
learning disability in the UK and we employed robust method-
ology to define the cohorts with and without learning disability
who are eligible for screening for four different types of cancer, in
accordance with UK health policy. The cohort design accounted
for the amount of follow-up time available for each patient within
the database, and we restricted our analysis to four main outcomes
and a limited number of tests for interactions which were pre-
determined by clinical hypotheses, namely that differential rates
would vary over time, by area social deprivation and by country.
Our study only includes people who have received a general
practice code for learning disability and it is possible that some
people with such a disability were not identified. Severity of
learning disability was infrequently recorded by GPs and therefore
we were not able to explore the influence of the severity of the
condition on rates of cancer screening. The bowel and prostate
cancer screening schemes are relatively recent initiatives in the UK
and it maybe that further disparities may emerge as they become
more established with the UK population.
Clinical Implications
People with learning disability are less likely to have a record of
screening for breast, cervical, prostate and bowel cancer than
general practice patients of similar age and sex without learning
disabilities. The cervical screening results concur with a recent
NHS report regarding this group of patients [15]. However we
have provided stronger evidence by using more contemporary
data and by adjusting for follow-up time in THIN, by exploring
time trends and also evaluating breast, bowel and prostate cancer
screening. Interestingly, in the NHS report, rates of screening for
other conditions such as obesity, hypertension and diabetes were
similar in people with and without learning disability [15].
Therefore it appears there may be a specific challenge relating
to cancer screening in this group.
Explanations may lie at the level of the individual patient, their
carers, their health professionals, health policy or indeed the
uptake of screening by those in the comparison cohorts. When we
explored rates of exclusion from cancer screening, it was apparent
that primary care physicians are more likely to exclude people with
learning disability from being eligible for cervical cancer screening.
However we accounted for this in our analysis, and people with
learning disability were still less likely to be screened. It is also
possible that patients do not receive appropriate information that
encourages them to be screened for cancer, or that they choose not
to be screened even if they do receive such information. In our
study, the UK Department of Health guidance to improve cervical
and breast screening in people with learning disability did not have
Figure 2. Incidence rates for screening for four types of cancer in people with and without Learning Disability. The figure compares
rates of screening for cancer in eligible people with and without learning disability (LD), within the UK THIN primary care database from 1999–2009.
The four charts relate to cervical screening rates, mammography rates, screening for bowel cancer with faecal occult blood (FOB) tests, and screening
for prostate cancer with prostatic specific antigen tests (PSA).
doi:10.1371/journal.pone.0043841.g002
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a consistent discernible impact, since while relative rates of cervical
screening improved, the breast screening gap has widened over the
decade. Differences in the timing and nature of screening
programmes in the four countries of the UK might explain the
different findings we observed in the four countries of the UK. The
NHS is committed to addressing health inequalities and the
differential rates of cancer screening in people with learning
disability need greater publicity and ongoing monitoring to avoid
preventable physical morbidity. Other methods of reducing
inequalities in access to cancer screening for this group should
be considered.
The findings regarding social deprivation findings were contrary
to our hypotheses. They may reflect a combination of a relatively
higher uptake of screening by more affluent people without
learning disability and in contrast a relatively lower uptake of
screening in more deprived areas by people without learning
disability. An alternative explanation is that people with learning
disability may receive better care within geographical areas which
are more socially deprived. We have observed similar findings
when exploring cardiovascular screening for people with severe
mental illnesses such as schizophrenia [16]. Contrary to intuition,
differential screening rates were not more pronounced in areas of
greater social deprivation, and it is possible that services in more
deprived areas are more acclimatised to providing care for hard-
to-reach groups.
We have detected discrepancies in the rates of cancer screening
for people with learning disability, but analysis of routinely
collected clinical data cannot fully determine the reasons for these
inequalities. This would require primary research exploring the
reasons why uptake of screening differs in these groups. One
possibility is that people with learning disability have more
physical co-morbidities which might make it more difficult for
them to take up screening, but we did not have data to explore this
possibility.
Furthermore, our research did not focus on a physical health
outcome (ie cancer) within the cohorts and future research should
determine whether the differential rates of screening are reflected
by increased incidence rates for cancer in people with learning
disability.
Our research focussed on the NHS cancer screening pro-
grammes and it is worth noting that while the effectiveness of
cervical screening is well established for women over the age of 25
[17], there are still debates regarding the risks and benefits of
breast cancer screening programmes [18], and even more
uncertainty regarding the benefits of PSA tests in terms of prostate
cancer screening [19]. However we sought to determine whether
people with learning disability were receiving the screening
recommended for people of their agegroup and they were not.
As evidence emerges regarding the risks and harms of different
cancer screening tests, the nature of the cancer screening
programmes will inevitably change. However as a general
principle, people with learning disability should have similar
access to the best current physical health care as the general
population. Although practitioners might be concerned regarding
the possible psychological harm of cancer screening for vulnerable
groups such as those with learning disability, this is not in line with
national guidance for screening for this group of people [8].
Our results suggest that the introduction of various primary care
incentives such as the NHS Quality Outcomes Framework and
directed and local enhanced service schemes over the years may
have narrowed the differences in screening for cervical cancers in
people with learning disabilities but this is not the case for breast
cancer screening. Moreover, for all four type of cancer screening
there was a wide gap in the level of provision. Increased awareness
of general practice staff to these discrepancies is required and the
inclusion of more focussed cancer screening programmes as a part
of the either the NHS Quality Outcomes Framework or the NHS
Directed Enhanced Service schemes should be considered.
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